These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21127039)

  • 1. Molecular characterization of high-level fluoroquinolone resistance in a clinical isolate of Haemophilus parainfluenzae.
    Rodríguez-Martínez JM; López-Hernández I; Pascual A
    J Antimicrob Chemother; 2011 Mar; 66(3):673-5. PubMed ID: 21127039
    [No Abstract]   [Full Text] [Related]  

  • 2. [High level of fluoroquinolone resistance in a respiratory isolate of Haemophilus parainfluenzae associated with a new mutation in ParC].
    López-Hernández I; Rodríguez-Martínez JM; Ortiz-de la Tabla V; Pascual A
    Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):636-7. PubMed ID: 23623581
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular characterization of a clinical Haemophilus parainfluenzae isolate with cefotaxime resistance and decreased susceptibility to fluoroquinolones.
    Faccone D; Lopez-Ruitti P; Vazquez M; Guerriero L; Lucero C; Gagetti P; Ceriana P; Corso A
    Infect Genet Evol; 2016 Oct; 44():507-509. PubMed ID: 27497656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of fluoroquinolone resistance in Haemophilus parasuis isolated from pigs in South China.
    Guo L; Zhang J; Xu C; Zhao Y; Ren T; Zhang B; Fan H; Liao M
    J Antimicrob Chemother; 2011 Mar; 66(3):539-42. PubMed ID: 21217127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of Fluoroquinolone-Resistant Haemophilus parainfluenzae Clinical Isolates in Spain.
    López-Hernández I; Machuca J; Díaz de Alba P; Sarvisé C; Gómez F; Rodríguez-Martínez JM; Pascual A
    Microb Drug Resist; 2017 Dec; 23(8):935-939. PubMed ID: 28414572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing resistance to fluoroquinolones among Haemophilus species in Southern Taiwan.
    Chang CM; Tang HJ; Wang LR; Shih HI; Huang CC; Lee NY; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2017 Apr; 50(2):258-260. PubMed ID: 27289531
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
    Arai K; Hirakata Y; Yano H; Kanamori H; Endo S; Hirotani A; Abe Y; Nagasawa M; Kitagawa M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Takayama Y; Yamamoto N; Kunishima H; Kaku M
    J Antimicrob Chemother; 2011 Mar; 66(3):494-8. PubMed ID: 21172783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila.
    Almahmoud I; Kay E; Schneider D; Maurin M
    J Antimicrob Chemother; 2009 Aug; 64(2):284-93. PubMed ID: 19474069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance.
    Cattoir V; Varca A; Greub G; Prod'hom G; Legrand P; Lienhard R
    J Antimicrob Chemother; 2010 Dec; 65(12):2514-7. PubMed ID: 20952417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
    Beeton ML; Chalker VJ; Kotecha S; Spiller OB
    J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.
    Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H
    Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancies in fluoroquinolone clinical categories between the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI for Escherichia coli harbouring qnr genes and mutations in gyrA and parC.
    Rodríguez-Martínez JM; Briales A; Velasco C; Díaz de Alba P; Martínez-Martínez L; Pascual A
    J Antimicrob Chemother; 2011 Jun; 66(6):1405-7. PubMed ID: 21427105
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in a clinical isolate of Streptococcus pneumoniae in the South Pacific.
    Le Hello S; Page S; Garin B
    Int J Antimicrob Agents; 2008 Jul; 32(1):91-2. PubMed ID: 18495439
    [No Abstract]   [Full Text] [Related]  

  • 16. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan.
    Baucheron S; Chaslus-Dancla E; Cloeckaert A; Chiu CH; Butaye P
    Antimicrob Agents Chemother; 2005 Feb; 49(2):862-3. PubMed ID: 15673791
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y; Pei X; Liu X
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.